Enanta Pharmaceuticals (NASDAQ:ENTA – Get Free Report) issued an update on its third quarter earnings guidance on Monday morning. The company provided earnings per share guidance of ($1.86) for the period, compared to the consensus earnings per share estimate of ($2.25). The company issued revenue guidance of $18.9 million, compared to the consensus revenue estimate […]
HC Wainwright restated their buy rating on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) in a research note published on Tuesday morning, Benzinga reports. They currently have a $48.00 target price on the biotechnology company’s stock. HC Wainwright also issued estimates for Enanta Pharmaceuticals’ Q2 2024 earnings at ($2.61) EPS, Q3 2024 earnings at […]
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Rating)’s stock price reached a new 52-week low during trading on Wednesday . The company traded as low as $22.80 and last traded at $23.75, with a volume of 211387 shares trading hands. The stock had previously closed at $23.80. Analysts Set New Price Targets ENTA has been the […]
Enanta Pharmaceuticals (NASDAQ:ENTA – Get Rating) had its target price reduced by research analysts at HC Wainwright from $68.00 to $48.00 in a report released on Tuesday, The Fly reports. HC Wainwright’s price objective points to a potential upside of 81.06% from the stock’s current price. Several other analysts also recently weighed in on the […]
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Get Rating) has been assigned an average rating of “Moderate Buy” from the eleven analysts that are currently covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 12-month price […]